- Home
- XPRO vs KOD Comparison
XPRO vs KOD Comparison
Compare XPRO & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XPRO | KOD |
|---|---|---|
| Founded | 1938 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | XPRO | KOD |
|---|---|---|
| Price | $15.98 | $22.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $14.00 | ★ $28.29 |
| AVG Volume (30 Days) | ★ 1.2M | 765.2K |
| Earning Date | 02-19-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 313.92 | N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $1,661,811,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.72 | N/A |
| P/E Ratio | $26.93 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.70 | $1.92 |
| 52 Week High | $16.79 | $31.18 |
Technical Indicators
Market Signals| Indicator | XPRO | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 58.89 | 39.08 |
| Support Level | $15.23 | $23.72 |
| Resistance Level | $16.45 | $26.79 |
| Average True Range (ATR) | 0.73 | 2.16 |
| MACD | 0.01 | -0.54 |
| Stochastic Oscillator | 63.20 | 0.60 |
Price Performance
Historical ComparisonAbout XPRO Expro Group Holdings N.V.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.